JP2008502735A5 - - Google Patents

Download PDF

Info

Publication number
JP2008502735A5
JP2008502735A5 JP2007527776A JP2007527776A JP2008502735A5 JP 2008502735 A5 JP2008502735 A5 JP 2008502735A5 JP 2007527776 A JP2007527776 A JP 2007527776A JP 2007527776 A JP2007527776 A JP 2007527776A JP 2008502735 A5 JP2008502735 A5 JP 2008502735A5
Authority
JP
Japan
Prior art keywords
acid
agent
composition
group
polyisoprenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007527776A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008502735A (ja
JP4987715B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/020555 external-priority patent/WO2005123103A1/en
Publication of JP2008502735A publication Critical patent/JP2008502735A/ja
Publication of JP2008502735A5 publication Critical patent/JP2008502735A5/ja
Application granted granted Critical
Publication of JP4987715B2 publication Critical patent/JP4987715B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007527776A 2004-06-12 2005-06-13 上皮関連状態のための局所用組成物及び方法 Expired - Fee Related JP4987715B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US57909304P 2004-06-12 2004-06-12
US60/579,093 2004-06-12
US65292105P 2005-02-14 2005-02-14
US60/652,921 2005-02-14
PCT/US2005/020555 WO2005123103A1 (en) 2004-06-12 2005-06-13 Topical compositions and methods for epithelial-related conditions

Publications (3)

Publication Number Publication Date
JP2008502735A JP2008502735A (ja) 2008-01-31
JP2008502735A5 true JP2008502735A5 (cg-RX-API-DMAC7.html) 2008-07-31
JP4987715B2 JP4987715B2 (ja) 2012-07-25

Family

ID=35509456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007527776A Expired - Fee Related JP4987715B2 (ja) 2004-06-12 2005-06-13 上皮関連状態のための局所用組成物及び方法

Country Status (13)

Country Link
EP (1) EP1765376B1 (cg-RX-API-DMAC7.html)
JP (1) JP4987715B2 (cg-RX-API-DMAC7.html)
KR (1) KR20070061516A (cg-RX-API-DMAC7.html)
CN (1) CN101039689B (cg-RX-API-DMAC7.html)
AU (1) AU2005254035B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0512021A (cg-RX-API-DMAC7.html)
CA (1) CA2579605C (cg-RX-API-DMAC7.html)
DK (1) DK1765376T3 (cg-RX-API-DMAC7.html)
ES (1) ES2420516T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA06014514A (cg-RX-API-DMAC7.html)
PT (1) PT1765376E (cg-RX-API-DMAC7.html)
RU (1) RU2007101243A (cg-RX-API-DMAC7.html)
WO (1) WO2005123103A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
US20130115320A1 (en) 2007-03-30 2013-05-09 Dynova Laboratories, Inc. Therapeutic agent for intranasal administration and method of making and using same
GB0823265D0 (en) * 2008-12-20 2009-01-28 Convatec Technologies Inc Antimicrobial Composition
JP2012515721A (ja) * 2009-01-20 2012-07-12 シグナム バイオサイエンシーズ, インコーポレイテッド 抗炎症性複合体
CA2683258C (en) * 2009-10-20 2011-08-09 Asa Bullion Investment Limited Lotion for cleaning human anorectal area
PT2498603T (pt) * 2009-11-12 2016-08-25 Signum Biosciences Inc Utilização de agentes antibacterianos para o tratamento de afecções relacionadas com o epitélio
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
EP2793833B1 (en) * 2011-12-20 2020-06-24 Vyome Therapeutics Limited Topical oil composition for the treatment of fungal infections
KR20150055024A (ko) * 2012-09-14 2015-05-20 엘리자베스 아덴, 인크. 이데베논, n-아세틸-s-파네실-l-씨스테인 및 에르고티오네인으로 구성되는 제제와 그 용도
BR112015014816A2 (pt) 2012-12-20 2017-07-11 Convatec Technologies Inc processamento de fibras celulósicas modificadas quimicamente
GB201308770D0 (en) 2013-05-15 2013-06-26 Convatec Technologies Inc Wound Dressing Comprising an Antimicrobial Composition
CN104739758A (zh) * 2013-12-30 2015-07-01 天津高科生产力促进有限公司 N-乙酰-l-半胱氨酸含漱液
TWI687405B (zh) * 2016-03-16 2020-03-11 慧穎應用生物科技有限公司 一種沉香樹籽萃取物、製備方法及其應用於抗過敏之用途
CA3032453A1 (en) * 2016-08-08 2018-02-15 Signum Biosciences, Inc. Pharmaceutical formulations and their use
FR3104943B1 (fr) * 2019-12-19 2022-05-13 Oreal Lipoaminoacides et leurs utilisations comme actif antipelliculaire
CN111773212A (zh) * 2020-08-14 2020-10-16 云南中医药大学 一种瑞香素的应用
CN111909069B (zh) * 2020-08-25 2022-04-19 安徽启威生物科技有限公司 一种可降解的季铵盐化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849576A (en) * 1964-01-29 1974-11-19 Oreal Process and cosmetic compositions for the treatment of skin and scalp
US5043268A (en) * 1990-05-04 1991-08-27 The Trustees Of Princeton University Substrates and inhibitors for prenyl cysteine methyltransferase enzymes
US5202456A (en) * 1991-04-15 1993-04-13 The President And Fellows Of Harvard College Compounds for inhibition of protein methylation
IL107587A (en) * 1993-11-12 1998-08-16 Univ Ramot Farnesyl geranyl or geranyl-geranyl derivatives pharmaceutical compositions containing them and methods for their preparation
US6372793B1 (en) * 1999-08-20 2002-04-16 Florida Agricultural & Mechanical University Method for treatment of a neurological disease characterized by impaired neuromodulator function
US20030228688A1 (en) * 2002-05-31 2003-12-11 Isis Pharmaceuticals Inc. Antisense modulation of isoprenylcysteine carboxyl methyltransferase expression
US20070004803A1 (en) * 2003-03-26 2007-01-04 Purdue Research Foundation Compounds and methods for use in treating neoplasia and cancer based upon inhibitors of isoprenylcysteine methyltransferase

Similar Documents

Publication Publication Date Title
US8313782B2 (en) Acne vulgaris treatment regimen
US4657901A (en) Pharmaceutical composition
US20190255078A1 (en) Topical compositions with stable solubilized selective retinoids and/or tetracycline-class antibiotics
JP2016138154A (ja) 発毛を刺激する組成物および方法
US20120289521A1 (en) Treatment of Acne and Other Diseases
WO2011014627A1 (en) Combination of dapsone with adapalene
US20050137164A1 (en) Diclofenac compositions for the treatment of skin disorders
US7074832B2 (en) Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
KR20110036683A (ko) 피부 치료용 벤조일 퍼옥사이드 조성물
CA2902977A1 (en) Acne solution
JP4987715B2 (ja) 上皮関連状態のための局所用組成物及び方法
JP2014501776A (ja) 座瘡の治療のためのメラトニン及び殺菌剤又は抗菌剤
JP2004516259A (ja) 色素過剰症を治療するための組成物および方法
US5948822A (en) Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
US7060729B2 (en) Composition and method for treating skin
JP2015081244A (ja) ニキビ治療用医薬組成物
JP7744739B2 (ja) アラントイン及び/又はその誘導体の安定化方法
JP2024516316A (ja) 萎縮性瘢痕を治療するためのキヌレニンおよびその誘導体
RU2704109C2 (ru) Комбинация ретиноида и диола и эфира полиненасыщенной жирной кислоты
Toama et al. Modalities in acne vulgaris treatment
JPH0471053B2 (cg-RX-API-DMAC7.html)
JP7733991B2 (ja) 外用組成物
JP2009519303A (ja) 少なくとも1種のレチノイド化合物と、少なくとも1種の抗刺激剤化合物とを含む組成物およびその使用
JP7733992B2 (ja) 外用組成物
EP1818058A2 (en) Treatment of mmp-mediated dermatological diseases with pemirolast